edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Christian Glennie, Healthcare Analyst at Edison, discusses the investment case for Sucampo Pharmaceuticals, a US-based pharmaceutical company, which recently obtained regulatory approval for an important new use of its constipation drug, Amitiza. The approval caused a major re-rating of the stock and Christian reviews further potential catalysts, the key challenges for Sucampo and his approach to valuing the company.
Get access to the very latest content matched to your personal investment style.